Become a NASH PASS Strategic Site Partner

NASH PASS is an IRB-approved clinical protocol that provides clinical trial sites and healthcare providers the tools, methodology, and support to diagnose and monitor at-risk patients for the progression of NAFLD and NASH. The NASH PASS program also provides qualified principal investigators and diagnosed patients the opportunity to participate in clinical trials investigating new NAFLD and NASH drug candidates.